Close Menu

NEW YORK (GenomeWeb) – A prospective, population-based study in Stockholm has shown that a prostate cancer screening method combining plasma protein biomarkers, genetic polymorphisms, and clinical variables may reduce the overdiagnosis that can occur with standard prostate-specific antigen screening.

The study was the result of an ongoing research collaboration between Thermo Fisher Scientific and Henrik Grönberg in Karolinska Institute's department of medical epidemiology and biostatistics.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Oil made from gene-edited soybeans is already in use, according to the Associated Press.

USA Today reports that Department of Veterans Affairs is teaming up with Sanford Health to provide veterans with genetic testing.

Mother Jones reports there are few regulations overseeing the use of genetic genealogy by law enforcement.

In Science this week: analysis of ancient DNA recovered from Iberian populations, and more.

Mar
27
Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost.